Nasdaq’s Top Decile Stocks Post 164% Rally, Regeneron Gains 48%
The Nasdaq’s top decile stocks delivered a 164% one-year return, eclipsing the 159% peak in 2000; Regeneron’s shares have risen 48% over the past 12 months, placing it among this cohort. This chart analysis highlights a rare market breadth driven by major sector leaders.
1. Record High One-Year Returns
The top decile of Nasdaq stocks achieved an average 164% return over the last 12 months, surpassing the 159% one-year record set in March 2000.
2. Regeneron Among Top Performers
Regeneron ranks within the top five of these winners, with shares up 48% year over year, reflecting strong demand for its biotech pipeline.
3. Sector Leadership Drives Gains
Sector heavyweights in technology and biotech, led by AI and immunology names, accounted for the lion’s share of the rally.
4. Outlook and Risks
While momentum is strong, valuations now far exceed historical norms, raising concerns over a potential market correction.